MALAT1 and osteosarcoma: BMSC-EVs can transfer MALAT1 into osteosarcoma cells, thus increasing the expression of MALAT1 and NRSN2, reducing the expression of miR-143, and activating Wnt/β-catenin pathway in osteosarcoma cells (26).